Epidemiology of hypertension and chronic kidney disease in China

被引:30
|
作者
Chen, Jing [1 ,2 ]
机构
[1] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA
[2] Tulane Univ, Sch Med, Tulane Hypertens & Renal Ctr Excellence, New Orleans, LA 70112 USA
来源
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION | 2010年 / 19卷 / 03期
基金
美国国家卫生研究院;
关键词
China; chronic kidney disease; hypertension; DIETARY-SODIUM INTERVENTION; BLOOD-PRESSURE RESPONSES; STAGE RENAL-DISEASE; SALT-SENSITIVITY; CARDIOVASCULAR-DISEASE; GLOBAL BURDEN; RISK; PREVALENCE; POPULATION; ADULTS;
D O I
10.1097/MNH.0b013e328337f921
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review Hypertension and chronic kidney disease have become major public health challenges in China. Recent findings It is estimated that approximately 153 million Chinese adults had hypertension in 2002. It is also estimated that 2.33 million total cardiovascular deaths and 1.27 million premature cardiovascular deaths were attributable to increased blood pressure in 2005 in China. Approximately 39% of Chinese adult populations are highly sensitive to dietary sodium intake, a risk factor for hypertension and cardiovascular disease. The prevalence of chronic kidney disease varied greatly among studies due to differences in study populations and definitions of chronic kidney disease. A large prospective cohort study estimates that incidence and mortality of end-stage renal disease was 30.7 and 20.9 per 100 000 person-years among Chinese adults aged 40 years and older. Hypertension and the metabolic syndrome have been documented as risk factors for chronic kidney disease. In addition, a J-shaped association between body weight and incidence of end-stage renal disease and an inverse association between alcohol consumption and risk of end-stage renal disease were documented. Summary These results underscore the urgent need to develop national strategies for the prevention, detection, and treatment of hypertension and chronic kidney disease.
引用
收藏
页码:278 / 282
页数:5
相关论文
共 50 条
  • [41] Nocturnal Hypertension and Chronic Kidney Disease
    Fukuda, Michio
    Mizuno, Masashi
    Kimura, Genjiro
    CURRENT HYPERTENSION REVIEWS, 2011, 7 (01) : 5 - 8
  • [42] Pulmonary Hypertension in Chronic Kidney Disease
    Travers, Alison
    Farber, Harrison W.
    Sarnak, Mark J.
    CARDIOLOGY CLINICS, 2021, 39 (03) : 427 - 434
  • [43] Obesity, hypertension, and chronic kidney disease
    Hall, Michael E.
    do Carmo, Jussara M.
    da Silva, Alexandre A.
    Juncos, Luis A.
    Wang, Zhen
    Hall, John E.
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2014, 7 : 75 - 88
  • [44] Hypertension management in chronic kidney disease
    Mallamaci, Francesca
    Pisano, Anna
    Tripepi, Giovanni
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (12) : 2194 - 2195
  • [45] Hypertension in patients with chronic kidney disease
    Ranjan Chanda
    Andrew Z. Fenves
    Current Hypertension Reports, 2009, 11 : 329 - 336
  • [46] Treatment of Hypertension in Chronic Kidney Disease
    Kalaitzidis, Rigas G.
    Elisaf, Moses S.
    CURRENT HYPERTENSION REPORTS, 2018, 20 (08)
  • [47] HYPERTENSION IN CHILDREN WITH CHRONIC KIDNEY DISEASE
    Dryl, Inna
    Gonchar, Margaryta
    Kolibaeva, Tetyana
    Pidvalnaja, Nataly
    Muratov, Georgy
    Pushkar, Olena
    Khmara, Nataly
    Petrenko, Ielizaveta
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 746 - 746
  • [48] Hypertension management in chronic kidney disease
    Liddell, Toddra S.
    Henry-Okafor, Queen
    Umeukeje, Ebele M.
    NURSE PRACTITIONER, 2024, 49 (07): : 13 - 20
  • [49] Epidemiology, major outcomes, risk factors, prevention and management of chronic kidney disease in China
    Xie, Yuansheng
    Chen, Xiangmei
    AMERICAN JOURNAL OF NEPHROLOGY, 2008, 28 (01) : 1 - 7
  • [50] Epidemiology of chronic kidney disease: an update 2022
    Kovesdy, Csaba P.
    KIDNEY INTERNATIONAL SUPPLEMENTS, 2022, 12 (01) : 7 - 11